Location: Home
  • search
  • go
  • Relate News
  • 11/12/2018Leading MNCs Tout Renewed China Business Growth in Q3
  • 11/12/2018BeiGene Delays US Filing for BTK Inhibitor Zanubrutinib
  • 11/12/2018Eisai Launches HCC Drug LENVIMA (lenvatinib) in China
  • 11/12/2018SAMR Solicits Comments on Production Licensing Regulation for Formulat...
  • 11/11/2018Merck KGaA Paves the Way for its Innovation Hub in Southern China
  • 11/9/2018Performance of Chinese Pharmaceutical Industry on Steady Growth in 3Qs...
  • 11/9/2018Recent Executive Moves
  • 11/8/2018Amyris Further Expands Relationship with Yifan Pharma
  • 11/8/2018Leading Chinese Pharma Companies by R&D Spending in 3Qs/2018
  • 11/7/2018Production of Trustworthy Real World Data and Evidence in China
  • 11/7/2018Zambon Boosts Export of Fluimucil to China in Partnership with AstraZ...
  • 11/5/2018EyePoint Pharma and Ocumension Sign Exclusive License for Uveitis in G...
  • 11/5/2018Mapi Pharma Closes $10M Investment by Zhejiang Jingxin Pharma
  • 11/5/2018Automation Could Help China Capture Pharma Manufacturing Lead
  • 11/5/2018Most Domestically-listed Medical/Pharma Companies Report Positive Resu...
  • 11/5/2018NMPA Launches New Official Website
  • 11/2/2018Issues in Chinese Foreign Direct Investment in U.S. Early Stage Biotec...
  • 11/2/2018Sanofi Witnesses China Revenues Growing 17.7% in Q3/2018
  • 11/2/2018111, Inc. Establishes Strategic Partnership with A. Menarini China
  • 11/2/2018NPC Solicits Comments on Drug Administration Law and Essential Healthc...
  • 11/2/2018Recent Executive Moves
  • 11/2/2018Warburg Pincus Acquires DKSH’s China Healthcare Business for US$100M
  • 11/1/2018NHSA Announces 17 Departmental Level Senior Official Appointments
  • 11/1/2018GeneQuantum and Biocytogen Partners on Development of Antitumor Biocon...
  • 11/1/2018By-Health and Bioiberica Partner on New Bone Joint Care Products
  • 10/31/2018NMPA and NHC Release New Rule for Evaluation of Urgently Needed Foreig...
  • 10/30/2018NMPA Issues Two Bioequivalence Study Guidelines
  • 10/29/2018Leading Chinese Pharma Companies by R&D Spending in H1/2018
  • 10/26/2018Recent Executive Moves
  • 10/26/2018Bispecific Antibodies in China
  • Page:156/361 Total number of articles:10802: [First][<<] [154] [155] [156] [157] [158] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group